Author

Philip J. Tofilon

National Cancer InstituteORCID 0000-0003-0170-1194Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Beata MałachowskaiD· 1 shared Brett I. BelliD· 1 shared Chandan GuhaiD· 1 shared David ShechteriD· 1 shared Dejauwne L. YoungiD· 1 shared Jacob S. RothiD· 1 shared Jennifer T. AguilaniD· 1 shared Joseph D. DeAngeloiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Beata MałachowskaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintApr 11, 2025

Loss of CARM1 alters the developmental programming of Glioma stem-like cells and creates a druggable NGFR/NTRK dependency

Dejauwne L. Young, Jennifer T. Aguilan, Ronald R. Cutler…·Simone Sidoli

This study shows that CARM1 loss in GSCs disrupts developmental programming, shifts lineage towards radial glia, and creates a dependency on NGFR/NTRK signaling, making them vulnerable to NTRK inhibitors.

DOI 10.1101/2025.04.11.647869

humanbulk RNA-seq

𝕏 PostBluesky